Veteran investor and executive with broad experience in corporate finance, strategic partnerships and operational leadership. Denise Reinert brings a market-focused approach to sourcing growth-stage and turnaround opportunities across technology, healthcare and services. She has led capital raises, portfolio governance and operational transformations while working with private equity and venture-backed companies. Background combines senior roles in corporate development and operating teams with an education oriented to finance and management. Typical focus: growth equity, cross-border expansion and board-level oversight.
Veteran investor and executive with broad experience in corporate finance, strategic partnerships and operational leadership. Denise Reinert brings a market-focused approach to sourcing growth-stage and turnaround opportunities across technology, healthcare and services. She has led capital raises, portfolio governance and operational transformations while working with private equity and venture-backed companies. Background combines senior roles in corporate development and operating teams with an education oriented to finance and management. Typical focus: growth equity, cross-border expansion and board-level oversight.
Adopts a market-driven growth equity and turnaround orientation, prioritizing scalable technology, healthcare and services franchises with clear paths to operational improvement. Prefers minority-to-control investments where capital and board guidance accelerate cross‑border expansion, revenue scaling and margin restoration. Underwrites deals with fundamental diligence, conservative leverage and milestone-based capital deployment, emphasizing hands-on portfolio governance, operational playbooks and 3–7 year value-creation horizons to de-risk exits.
Adopts a market-driven growth equity and turnaround orientation, prioritizing scalable technology, healthcare and services franchises with clear paths to operational improvement. Prefers minority-to-control investments where capital and board guidance accelerate cross‑border expansion, revenue scaling and margin restoration. Underwrites deals with fundamental diligence, conservative leverage and milestone-based capital deployment, emphasizing hands-on portfolio governance, operational playbooks and 3–7 year value-creation horizons to de-risk exits.
| Trades 1541 | Longs Won 1041/1541 67% | Profit Factor 18.11 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $513,828.07 |
| Average Win $86,682.35 | Best Trade (Oct 16) $11.91M | Sharpe Ratio -38.75 |
| Average Loss -$9,964.18 | Worst Trade (Oct 15) -$1.06M | Z-Score 7.9 (100%) |
| Commissions $0 | Avg. Trade Length 1y 6m 4w 1d | Expectancy $55,323.97 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 45,455 | 40,909 | 36,364 | 31,818 | 27,273 | 22,727 | 18,182 | 13,636 | 9,091 | 4,545 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
| 2523 25239Y162 | 942 | $62,586 | $62,586 | - | - | - | 0.0 |
| 2523 25239Y212 | 1,070 | $47,562 | $47,562 | - | - | - | 0.0 |
AAPL Apple Inc. | 15,675 | $3.34M | $5.4M | - | $2.06M | 61.83% | +0.751% |
ABBV AbbVie Inc. | 773 | $124,978.36 | $220,243.16 | - | $95,264.8 | 76.23% | +0.536% |
ABT Abbott Laboratories | 464 | $51,628.2 | $48,585.44 | - | -$3,042.76 | -5.89% | +0.029% |
ACN Accenture plc Class A | 47 | $15,622.51 | $10,653.25 | - | -$4,969.26 | -31.81% | +0.776% |
ADBE Adobe Inc. | 567 | $277,522.69 | $139,277.88 | - | -$138,244.81 | -49.81% | -2.396% |
ADI Analog Devices, Inc. | 94 | $25,492.8 | $38,201.6 | - | $12,708.8 | 49.85% | +0.607% |
ADNT Adient plc | 9 | $330 | $164.16 | - | -$165.84 | -50.25% | +0.33% |
ADP Automatic Data Processing Inc. | 323 | $79,228.11 | $92,487.82 | - | $13,259.71 | 16.74% | +0.242% |
AEE Ameren Corporation | 95 | $9,916 | $10,044.35 | - | $128.35 | 1.29% | +1.899% |
AEP American Electric Power Company, Inc. | 61 | $7,995.94 | $7,728.76 | - | -$267.18 | -3.34% | +1.94% |
AIRR First Trust RBA American Industrial Renaissance ETF | 24 | $2,478 | $2,390.64 | - | -$87.36 | -3.53% | -0.797% |
AM Antero Midstream Corporation | 500 | $5,800 | $10,112.5 | - | $4,312.5 | 74.35% | +1.531% |
AMAT Applied Materials, Inc. | 172 | $26,011.12 | $71,835.8 | - | $45,824.68 | 176.17% | -2.874% |
AMCR Amcor plc | 432 | $17,172 | $18,997.2 | - | $1,825.2 | 10.63% | +0.537% |
AMGN Amgen Inc. | 175 | $50,157.43 | $76,122.37 | - | $25,964.94 | 51.77% | +0.22% |
AMLP Alerian MLP ETF | 325 | $12,917.25 | $16,991 | - | $4,073.75 | 31.54% | +0.713% |
AMP Ameriprise Financial, Inc. | 116 | $61,913 | $58,081.2 | - | -$3,831.8 | -6.19% | -0.374% |
AMT American Tower Corporation | 32 | $6,323.03 | $5,881.28 | - | -$441.75 | -6.99% | +1.34% |